Item Type | Name |
Concept
|
Interleukin-1
|
Concept
|
Interleukin-2
|
Concept
|
Receptors, Interleukin-2
|
Concept
|
Interleukin-4
|
Concept
|
Interleukin-6
|
Concept
|
Interleukin-7
|
Concept
|
Interleukin-10
|
Concept
|
Interleukin-9
|
Concept
|
Interleukin-11
|
Concept
|
Receptors, Interleukin
|
Concept
|
Interleukin-12
|
Concept
|
Interleukin-17
|
Concept
|
Interleukin-18
|
Concept
|
Receptors, Interleukin-7
|
Concept
|
Interleukin-1beta
|
Concept
|
Interleukin-2 Receptor beta Subunit
|
Concept
|
Interleukin-7 Receptor alpha Subunit
|
Concept
|
Receptors, Interleukin-12
|
Concept
|
Interleukin-12 Receptor beta 1 Subunit
|
Concept
|
Receptors, Interleukin-18
|
Concept
|
Interleukin-18 Receptor alpha Subunit
|
Concept
|
Interleukin-23
|
Concept
|
Interleukin-23 Subunit p19
|
Concept
|
Interleukin-12 Subunit p40
|
Concept
|
Interleukin-12 Subunit p35
|
Academic Article
|
Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
|
Academic Article
|
Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance.
|
Academic Article
|
Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population.
|
Academic Article
|
The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.
|
Academic Article
|
IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
|
Academic Article
|
Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.
|
Academic Article
|
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.
|
Academic Article
|
Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling.
|
Academic Article
|
IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells.
|
Academic Article
|
Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-? (+)-producing CD4 (+) T cells.
|
Academic Article
|
Independent and Interdependent Immunoregulatory Effects of IL-27, IFN-ß, and IL-10 in the Suppression of Human Th17 Cells and Murine Experimental Autoimmune Encephalomyelitis.
|
Academic Article
|
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
|
Academic Article
|
The role of IL-12 in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
|
Academic Article
|
Study of disabling T-cell activation and inhibiting T-cell-mediated immunopathology reveals a possible inverse agonist activity of CD4 peptidomimetics.
|
Academic Article
|
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
|
Academic Article
|
Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system.
|
Academic Article
|
Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia.
|
Academic Article
|
Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
|
Academic Article
|
Early administration of IL-12 suppresses EAE through induction of interferon-gamma.
|
Academic Article
|
Role of the IL-12/IL-23 system in the regulation of T-cell responses in central nervous system inflammatory demyelination.
|
Academic Article
|
IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.
|
Academic Article
|
Astrocytes as antigen-presenting cells: expression of IL-12/IL-23.
|
Academic Article
|
Loss of the surface antigen 3G11 characterizes a distinct population of anergic/regulatory T cells in experimental autoimmune encephalomyelitis.
|
Academic Article
|
Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.
|
Academic Article
|
Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia.
|
Academic Article
|
The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
|
Academic Article
|
Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
|
Academic Article
|
Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.
|
Academic Article
|
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.
|
Academic Article
|
Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways.
|
Academic Article
|
MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways.
|
Academic Article
|
Therapeutic potential of IL-27 in multiple sclerosis?
|
Academic Article
|
IL-23 drives pathogenic IL-17-producing CD8+ T cells.
|
Academic Article
|
Differential effect of IL-27 on developing versus committed Th17 cells.
|
Academic Article
|
Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis.
|
Academic Article
|
IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.
|
Academic Article
|
Suppression of murine experimental autoimmune encephalomyelitis by interleukin-2 receptor targeted fusion toxin, DAB(389)IL-2.
|
Academic Article
|
Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27.
|
Academic Article
|
IL-9 signaling affects central nervous system resident cells during inflammatory stimuli.
|
Academic Article
|
IL-12Rß2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
|
Academic Article
|
Induction of Peripheral Tolerance in Ongoing Autoimmune Inflammation Requires Interleukin 27 Signaling in Dendritic Cells.
|
Academic Article
|
Distinct Role of IL-27 in Immature and LPS-Induced Mature Dendritic Cell-Mediated Development of CD4+ CD127+3G11+ Regulatory T Cell Subset.
|
Academic Article
|
IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
|
Academic Article
|
Bone marrow dendritic cells deficient for CD40 and IL-23p19 are tolerogenic in vitro.
|
Academic Article
|
Interferon-?/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
|
Academic Article
|
Transcription Factor RUNX3 Mediates Plasticity of ThGM Cells Toward Th1 Phenotype.
|
Academic Article
|
IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.
|
Academic Article
|
IL-7Ra on CD4+ T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis.
|
Academic Article
|
Mouse monocytes express CD127 by immune cells, not LPS.
|
Academic Article
|
IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4?+?T cell-derived IL-10 production.
|